Our Science
The science that supports our mission: turning each patient’s biology into the right treatment, at the right time.
One Platform. One Mission.
Everything we do begins with a natural curiosity to solve problems that have gone unsolved for decades. Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.
Putting Patients First
Created to Move as Fast as Disease
Conditions like sepsis, pneumonia, and ARDS move fast – they don’t leave much time to figure out which treatment a patient will respond to.
Every clinical trial expands our biobank.
Every biobank insight sharpens our models.
And every published result gives clinicians another reason to trust what those models recommend.
It’s how we keep pace with patients whose biology can change by the hour, and how we stay true to a single mission: treating people as individuals, not protocols.
Action in Science
Platform for Acute Care
Precision medicine for acute care begins with a research and development strategy built on one of the largest acute illness biobanks in existence. Combined with a clinical trial network of the nation’s leading academic research centers and a growing library of peer-reviewed evidence, this is how we create the nation’s only precision medicine platform for acute care.
From Biobank to Bedside
We pair biomarkers and EMR data across thousands of patients to understand and predict how each individual patient will respond to treatment.
Conclusions Backed by Data
Before we brought our first product to market, we spent a decade building the evidence behind it. That discipline continues today, with peer-reviewed publications in scholarly journals.
Right Treatment. Right Patient.
The nation’s top academic research sites are part of our clinical trial network, where we work to identify which patients respond to which treatments, and train our models to recognize those patterns in the future.